Aging Drug Portfolios Putting Pressure on Pharmaceutical Marketing, Accenture Study Finds
NEW YORK and FRANKFURT; Aug. 3, 2010 – In 2011, 40 percent of the highest-selling drugs will be products whose patent protection has either already expired or will do so in the coming two years, according to an analysis by Accenture (NYSE: ACN). In 2007, the share of such so-called mature products accounted for only 15 percent of the portfolios of pharmaceutical companies.
August 03, 2010
Accenture Announces $550 Million, 10-year Agreement with Bristol-Myers Squibb
NEW YORK; September 10, 2008 – Accenture (NYSE: ACN) announced today that it has signed a new 10-year, $550 million agreement with Bristol-Myers Squibb for a range of finance and accounting and application development and maintenance services.
September 10, 2008
Internet Vies with Pharmacists as U.S. Consumers' Second-Most-Trusted Source for Medication Information, Accenture Survey Finds
U.S. consumers trust the Internet nearly as much as they do pharmacists as a resource from which to learn about medications, according to the results of a survey released today by Accenture (NYSE:ACN).
April 10, 2006
Recent Drug Recalls Leave Physicians and Consumers Concerned about Prescription Drug Safety, Accenture Study Finds
In light of recent prescription drug recalls, physicians and consumers alike are concerned about drug safety, agreeing that more should be done to monitor drugs for side effects after they are approved for market to ensure their safe use, according to results of a study released today by Accenture (NYSE: ACN).
July 27, 2005
Accenture and Adobe Develop Enterprise Portal for MHRA
Accenture and Adobe Systems Incorporated are helping the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK develop an online portal.
March 17, 2005
Pharmaceutical Companies Must Re-think Innovation Strategies to Address Pipeline Challenges, Accenture and CMR Research Finds
New research by Accenture and CMR International challenges the view that increased investment in early stage innovation alone will solve the productivity gap.
January 19, 2005
Pharmaceutical Industry Group Concludes First Phase of EPC/RFID Tests; Technology Could Improve Security, Expedite Recalls, Help Industry Meet Regulatory Requirements
Accenture announced results from tests run by a group of pharmaceutical manufacturers, distributors and retailers exploring the application of electronic product code (EPC) and radio frequency identification (RFID) technologies across the pharmaceutical supply chain.
September 28, 2004